Ikano Therapeutics' midazolam granted Orphan Drug designation
Links shared publicly online about this topic.
- 1,615total visits
Ikano Therapeutics' midazolam granted Orphan Drug designation
Ikano Therapeutics, Inc. announced today that it has received Orphan Drug designation for midazolam in the acute treatment of certain forms of epileptic seizure known as cluster seizures or alternatively, as acute repetitive seizures.
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Drug, News
Most Recently Shared on November 9, 2009 at 5:23 pm By:
Epilepsy News: Ikano Therapeutics' midazolam granted Orphan Drug designation: Ikano Therapeutics,.. http://digg.com/u1G1Yd
Advertisement
